buserelin has been researched along with Bone Loss, Osteoclastic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichigo, S; Imai, A; Matsunami, K; Takagi, H | 1 |
| Chambers, TJ; Gallagher, A; Tobias, JH | 1 |
| Minaguchi, H; Taga, M | 1 |
| Feng, W; Gold, E; Goulding, A | 1 |
| Fisher, L; Goulding, A | 2 |
| Corbey, RS; Doesburg, WH; Franssen, AM; Rolland, R; van 't Veen, AJ; Willemsen, WN | 1 |
| Ito, M; Okamura, H; Sakoda, Y | 1 |
| Gold, E; Goulding, A | 2 |
10 other study(ies) available for buserelin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study.
Topics: Adenomyosis; Adult; Biomarkers; Bone Remodeling; Bone Resorption; Buserelin; Diphosphonates; Female; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Leiomyoma; Leuprolide; Middle Aged; Pilot Projects; Retrospective Studies; Uterine Neoplasms | 2016 |
Effect of administration and subsequent cessation of buserelin on cancellous bone of female rats.
Topics: Animals; Bone Development; Bone Resorption; Buserelin; Drug Administration Schedule; Estradiol; Female; Injections, Subcutaneous; Organ Size; Ovulation; Progesterone; Rats; Rats, Wistar; Tibia; Time Factors; Uterus | 1994 |
Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing hormone agonist administration.
Topics: Adult; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Resorption; Buserelin; Collagen; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Leiomyoma; Middle Aged; Nafarelin; Uterine Neoplasms | 1997 |
Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Disease Models, Animal; Drug Interactions; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Organ Size; Rats; Rats, Inbred Strains; Tamoxifen; Uterus | 1992 |
Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Clomiphene; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Rats; Rats, Inbred Strains; Uterus | 1991 |
17 beta-estradiol protects rats from osteopenia associated with administration of the luteinising hormone releasing hormone (LHRH) agonist, buserelin.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Calcium Radioisotopes; Estradiol; Female; Hydroxyproline; Rats | 1991 |
Subcutaneous injection or infusion of gonadotropin releasing-hormone agonist buserelin in the treatment of enlarged uteri harboring leiomyomata.
Topics: Adult; Bone Resorption; Buserelin; Cholesterol; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Infusion Pumps; Injections, Subcutaneous; Leiomyoma; Luteinizing Hormone; Middle Aged; Uterine Neoplasms; Uterus | 1991 |
Calcium metabolism in premenopausal women treated by a Gn-RH agonist for uterine myoma.
Topics: Adult; Bone and Bones; Bone Density; Bone Resorption; Buserelin; Estradiol; Female; Humans; Leiomyoma; Menopause; Middle Aged; Osteoporosis; Receptors, LHRH; Uterine Neoplasms; Uterus | 1990 |
Buserelin-mediated osteoporosis: effects of restoring estrogen on bone resorption and whole body calcium content in the rat.
Topics: Animals; Body Weight; Bone and Bones; Bone Resorption; Buserelin; Calcium; Estradiol; Female; Femur; Hydroxyproline; Osteoporosis; Rats; Rats, Inbred Strains; Time Factors | 1990 |
A new way to induce oestrogen-deficiency osteopaenia in the rat: comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and composition.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Estradiol; Estrogens; Female; Organ Size; Ovariectomy; Rats; Uterus | 1989 |